The programme is designed to combine high calibre lectures and interactive discussions to provide an educational opportunity to update clinicians and allied professions in current issues within the management of diseases affecting haematology patients.

TOPICS COVERED

  • CLL
  • Relapsed CLL: Have the new therapies completely replaced chemotherapy?
  • AML
  • Evolution in the management of AML
  • ALL
  • MRD and blinatumomab
  • MRD relevance pre and post-transplant
  • Workshop in Myeloma
  • Upfront treatments
  • Relapse in myeloma
  • Patient-based discussion
  • MDS
  • New treatments and iron chelation
  • Infectious Diseases in Haematology
  • Hepatitis & TB
  • Lymphoma MDT – Carousel of Cases
  • Adolescent TYA and chemotherapy – OEPA/COPDac versus ABVD
  • Improving RCHOP? Update on trials in progress
  • Combined modality treatment in early Hodgkin lymphoma
  • Refractory late Hodgkin lymphoma
  • Hodgkin lymphoma – H10 vs RAPID vs HD12/16
  • Chemo free in follicular lymphoma
  • Treating an 84 year old – assessment factors
  • How to get patients to CAR T cell therapy – what’s happening in your region?

WHO SHOULD ATTEND?

  • Consultants 
  • Trainees 
  • Nurses 
  • Pharmacists
  • Scientists working in haematology

SPEAKERS

  • Professor Graham Jackson, NCCC Newcastle
  • Professor Gordon Cook Leeds Teaching Hospitals
  •  Dr Mike Dennis Christie Hospital, Manchester
  • Dr George Follows Addenbrooke’s Hospital, Cambridge
  • Professor Tim Illidge Christie Hospital, Manchester
  • Professor Graham Jackson NCCC Newcastle
  • Dr Jonathan Kell University Hospital of Wales, Cardiff
  • Dr Tobias Menne NCCC Newcastle
  • Dr Andrew McMillan Nottingham University Hospitals
  • Dr Wendy Osborne NCCC Newcastle
  • Dr Anne Parker Queen Elizabeth University Hospital, Glasgow


For more information, please contact Chloe Irlam: chloe@hartleytaylor.co.uk

  • 11:30 - 10/10/2019 to 17:45 - 10/10/2019
  • Manchester Hall, 36 Bridge Street, Manchester, M3 3BT, United Kingdom (Great Britain)